The Truth About Statins Quotes
by Barbara H. Roberts
You will find sharp, evidence backed statements that challenge the mainstream narrative about cholesterol lowering drugs. The author pulls no punches, and the quotes here reflect her willingness to call out systemic problems in medicine, from manipulated statistics to industry influenced guidelines.
What makes this book so quotable is that every line feels like a grenade tossed into a cozy room. Readers come away with quotable truths that are hard to forget, whether it is about the tiny real world benefit of statins or the enormous financial incentives behind their promotion. These are lines that stick with you and make you question what you thought you knew.
Top Quotes from The Truth About Statins
“If you are a healthy woman, there is zero evidence that taking a statin will lower your risk of a heart attack or of dying of heart disease.”
The author summarizes the evidence for statins in healthy women.
This directly challenges the common prescription of statins to women with no proven benefit, empowering patients to question their doctor.
“It makes no sense at all to go on powerful medicines with the potential for serious, life-threatening side effects—for decades—when they have no proven benefit.”
The author argues against prescribing statins to healthy young women.
It highlights the irrationality of long-term drug use with no benefit and significant risks, resonating with those skeptical of overmedication.
“Since the likelihood of experiencing a statin side effect is about 20 percent to 25 percent, the risk of putting a healthy woman on a statin far outweighs the benefit.”
From the analysis of primary prevention trials, the author contrasts the negligible benefit with the known side-effect rate.
This sentence crystallizes the risk-benefit imbalance in a way that is easy to grasp and forces readers to reconsider the routine prescribing of statins to healthy women.
“The absolute risk reductions in these three trials were a paltry 1 percent to 2 percent.”
Describing the results of primary prevention trials, the author notes the tiny absolute benefit despite large relative risk reductions.
The word 'paltry' is emotionally charged and underscores how modest the real benefit is, cutting through the hype of relative risk numbers.
“You need to quote Hitler: the bigger the lie, the more people believe it.”
B.P., frustrated by the medical establishment's downplaying of statin risks, tells the author this.
The shocking comparison underscores the perceived deception in how statin benefits are promoted, provoking strong emotional and ethical reflection.
“So thirty-five of those women treated for five years would derive no measurable benefit, at a cost of $223,562.50 (assuming a cost per pill of $3.50).”
The author calculates the number needed to treat and the cost for women in the JUPITER trial.
This stark financial and human cost quantification makes the waste of resources tangible and challenges the value of widespread statin use in healthy women.
“When researchers present the results of clinical trials, and particularly when Big Pharma publicizes the results of successful trials, they report the relative risk reduction because it always sounds more impressive than the absolute risk reduction, which may be quite small even though it is statistically significant.”
The author explains the difference between relative and absolute risk reduction in the context of clinical trial reporting.
It exposes a common manipulation tactic used to exaggerate the perceived benefit of drugs, making readers aware of deceptive statistics.
Themes Behind the Quotes
One major theme is the disconnect between perceived and actual benefits of statins, especially for healthy women. The book stresses that absolute risk reductions are often tiny, while side effects are common and sometimes devastating. Another theme is the corrosive influence of pharmaceutical money on medical research and practice, where conflicts of interest blur the line between patient welfare and corporate profit.
A third theme is the power of lifestyle changes to achieve similar or better results without any of the risks. The quotes also highlight a deep sense of betrayal felt by patients who trusted their doctors and suffered irreversible harm. Finally, the book repeatedly calls out the misleading use of relative risk statistics to exaggerate benefits, a tactic that keeps patients on drugs they may not need.
Quotes by Chapter
— Chapter 1 — My Doctor Wants Me to Take a Statin — What Questions Do I Need to Ask ?
“Many doctors read that the “optimal” LDL cholesterol is under 100, and they come away feeling that anyone whose LDL cholesterol is over that number should be on medicine.”
The author explains a common misinterpretation of cholesterol guidelines by physicians.
This reveals a key reason for overprescription, making patients aware that their doctor may be oversimplifying complex guidelines.
“The issue of conflict of interest bedevils medical science to a greater extent today than at any time in history.”
The author discusses financial ties between researchers and pharmaceutical companies.
It captures a systemic ethical problem that undermines trust in medical recommendations, prompting readers to seek independent information.
— Chapter 2 — When Statins Help Most , and When They May Not Help at All
“In women without vascular disease or its equivalent, statins will not lower the risk of cardiac events at all.”
This conclusion appears near the end of the chapter, summarizing the results of primary prevention trials in women.
This is a stark, definitive statement that directly contradicts the widespread marketing of statins for all women, making it highly memorable and challenging to conventional practice.
“Guess which number gets touted when these clinical trials are reported?”
This rhetorical question follows the explanation of absolute versus relative risk reduction in clinical trial reporting.
It succinctly exposes the spin used by pharmaceutical marketing and media, leaving readers to draw the obvious conclusion.
— Chapter 3 — Common Side Effects of Statins : Cautionary Tales
“I am an attorney and still searching for ways to get better. However, sixteen doses of that 40 milligrams of simvastatin have ruined my health and my career.”
A.G., an attorney, describes the devastating impact of a short course of a statin drug.
This line starkly illustrates how a brief medical intervention can permanently destroy a person's livelihood and well-being, making the risk tangible and personal.
“I have cognitive difficulties that relate back to that first week in Vegas when I was missing entire conversations.”
A.G. recounts the sudden onset of cognitive problems after starting simvastatin.
It highlights a side effect often overlooked—cognitive impairment—and ties it to a specific, relatable moment, making the loss of mental clarity vivid and disturbing.
“While we accept a significant chance of adverse effects when medicines are given to treat deathly ill people who might die, we need to have a lower tolerance for side effects if we are treating healthy people to bring about a small reduction in the risk of some future event that is unlikely to occur for many years.”
The author, Dr. Barbara H. Roberts, argues for a stricter risk-benefit calculus in preventive medicine.
This sentence crystallizes the ethical dilemma of medicating healthy individuals, challenging readers to reconsider the justification for widespread statin use.
“Especially when lifestyle changes that carry no risk can accomplish the same result.”
The author contrasts the risks of statins with the safety of lifestyle modifications.
It delivers a powerful, succinct reminder that safer alternatives exist, undercutting the rationale for prescribing drugs to low-risk patients.
— Chapter 4 — Why Can’t a Woman Be More Like a Man ? Gender Differences and Statin Use
“It’s destroyed me. I’ve lost my income; I’ve lost everything. I've lost my friends because I don’t remember them.”
B.P., a television writer who suffered severe side effects from simvastatin, describes the devastating impact on her life.
This raw, personal testimony illustrates the human cost of statin side effects, making abstract risks feel tragically real.
“When I was in medical school, my professors took the “bikini approach” to women's health: women’s health meant breasts and reproductive organs.”
The author reflects on the historical neglect of women's health in medical education.
This vivid metaphor concisely captures how medicine once ignored women beyond reproductive organs, highlighting systemic bias that persists.
— Chapter 5 — So What Am I to Do ? Practical Lifestyle Approaches to Heart Health
“I felt, almost physically, that the multiple threads that had connected me to the world throughout my life were now being severed one after another, at an oddly accelerated pace.”
A patient describes the profound emotional and physical decline he experienced while on a statin.
This metaphor vividly captures the total loss of identity and joy, making the patient's suffering visceral and deeply relatable.
“I knew I would never touch a statin again in my life.”
The patient, after Googling 'statin and muscle aches,' makes a decisive resolution.
This short, declarative sentence conveys the moment of clarity and empowerment after years of unexplained suffering.
“In other words, you can lower the risk of cardiac events in people who've already had a heart attack without lowering their LDL cholesterol levels. That is not the kind of information Big Pharma wants you to have.”
The author comments on the results of the Lyon Diet Heart Study.
This challenges the statin-centric narrative and highlights how financial interests may suppress dietary solutions.
“You can drop your bad cholesterol the same amount with diet as you can with a statin.”
The author summarizes findings from a study comparing the Portfolio diet to statin therapy.
This direct, evidence-based statement offers hope and a non-pharmaceutical alternative, resonating with readers seeking lifestyle changes.
— Chapter 6 — The Chinese Got There First : Red Rice Yeast and the Dawn of the Statin Era
“She's not a complainer, but I would wake up, and she’d be crying in pain.”
R.H.'s husband describes her suffering from statin-induced muscle pain.
This simple, heartfelt line humanizes the severe side effects of statins, making the reader feel the real-world anguish behind medical statistics.
“This woman meets the current guidelines for drug treatment of her lipid levels, but a statin caused her to suffer severe side effects, affecting both muscles and nerves, which took years to resolve.”
The author concludes R.H.'s story, noting the contradiction between guidelines and harm.
It powerfully illustrates the disconnect between population-level treatment recommendations and the devastating individual consequences of those drugs.
“Often the first hint of a problem with supplements is that people start getting sick or dying from them.”
The author criticizes the FDA's limited oversight of herbal supplements.
This stark, memorable statement exposes a dangerous regulatory gap, resonating with readers concerned about the safety of unregulated products.
“So when you buy over-the-counter red rice yeast, you typically have no idea of the potency of the preparation or whether or not it contains other chemicals that are potentially harmful.”
Summarizing the findings of Dr. Gordon's study on red rice yeast variability.
It empowers consumers with a clear warning about the unpredictability and hidden risks of seemingly natural supplements.
— Chapter 7 — Big Pharma , the FDA , and the Medical Profession : An Unholy , Very Lucrative Alliance
“When a gift or a gesture of any size is bestowed, it imposes on the recipient a sense of indebtedness. The obligation to directly reciprocate, whether or not the recipient is directly conscious of it, tends to influence behavior.”
Bioethicist Dana Katz and colleagues writing in the American Journal of Bioethics in 2003, as cited by the author.
It succinctly captures the psychological mechanism behind even small gifts from pharmaceutical companies, challenging the common denial that such gestures have no effect on prescribing habits.
“The boundaries between academic medicine... and the pharmaceutical industry have been dissolving since the 1980s, and the important differences between their missions are becoming blurred. Medical research, education, and clinical practice have suffered as a result.”
Former New England Journal of Medicine editor Marcia Angell, quoted from her 2010 Boston Review article.
Powerfully states the core critique of the chapter—that the ethical and mission-driven divide between medicine and industry has eroded, harming patients and science.
“They have become little more than “hired hands” who supply the subjects for the trials, while they “collect data according to instructions from corporate paymasters.””
Dr. Angell's description of how academic medical centers now function in industry-funded clinical trials, as relayed by the author.
A sharp, memorable metaphor that demotes prestigious institutions to mere data collectors, exposing the loss of academic independence and scientific integrity.
“Big Pharma spends an estimated $30 billion a year on marketing. It is naive to believe that drug companies shell out that kind of money without proof that it works to increase sales.”
The author's own commentary after discussing the subconscious influence of gifts and the neurobiology of reciprocity.
Simple, factual, and damning—it forces readers to confront the obvious profit motive behind massive marketing budgets, undermining trust in the objectivity of industry-physician interactions.
— Chapter 9 — Clinical Research and the “ Science ” Being Used to Support Statin Use
“Unfortunately, in the realm of medical research, conflating association with causation has all too often led us down the wrong path.”
The author discusses the common error of confusing association with causation, using the example of cholesterol and heart disease.
This line succinctly captures a fundamental flaw in medical research that has led to widespread misinterpretation of data and misguided treatments.